5th World Congress on

2nd International Conference on&

JOINT EVENT

conferenceseries.com Scientific Program

Hepatitis & Liver Diseases

Pancreatic Cancer & Liver DiseasesAugust 10-12, 2017 London, UK

Conference Series-AmericaOne Commerce Center-1201, Orange St. #600, Wilmington, Zip 19899, Delaware, USA

P: +1-702-508-5200, F: +1-650-618-1417

Conference Series-UKKemp House, 152 City Road, London EC1V 2NX, Toll Free: +1-800-216-6499

Page 2

09:00-09:30 Registrations

Endeavour

Day 1 | August 10, 2017

Keynote ForumIntroduction

10:00-10:45Title: Lower GI bleeding in patients with cirrhosisMaxwell Chait, Columbia University, USA

10:45-11:30Title: Acute Pancreatitis TreatmentVincenzo Neri, University of Foggia, Italy

Panel DiscussionGroup Photo

Networking & Refreshment Break 11:30-11:45 @ Breakout AreasSessions: Hepatitis B | Hepatitis C | Hepatitis VaccinationSession Chair: Maxwell Chait, Columbia University, USA

Session Introduction

11:45-12:15Title: Hepatitis B Infection is now 30 times more common in UK than US children!Paul Desmond, Hepatitis B Positive Trust, UK

12:15-12:45Title: The Epidemiology of HCV and PWIDs in the United StatesSeth Kuranz, Decision Resources Group, USA

12:45-13:15Title: Access time to antiviral c treatment is equal for very fragile drug users and inmates, longer for drug centers patients: Interest in having a dedicated multidisciplinary teamAndré-Jean REMY, Perpignan Hospital, France

Lunch Break 13:15-14:00 @ RBG

14:00-14:30Title: Towards the first antibody-free serum biomarker assay for NAFLDBevin Gangadharan, University of Oxford, UK

14:30-15:00Title: Epidemiology and Disease Burden of Chronic Hepatitis C in Selected Middle Eastern CountriesAbdulrahman A Aljumah, King Saud bin Abdulaziz University for Health Sciences, Saudi Arabia

15:00-15:30Title: Immune persistence after hepatitis B vaccination in infancy: Fact or fancy?Terence T Lao, Chinese University of Hong Kong, Hong Kong

15:30-16:00Title: Hepatitis C and Sustainable Development Goals 2030Ruchika Sharma, Decision Resources Group, India

Networking and Refreshments Break: 16:00-16:15 @ Breakout Areas

16:15-16:45

Title: Clinical trials and pharmacology of HeberNasvac, a newly registered therapeutic vaccine for chronic Hepatitis B: Crossroad of biotechnology, adjuvant strategies and Liver ImmunologyJulio Cesar Aguilar Rubido, Center for Genetic Engineering and Biotechnology, Cuba

16:45-17:15Title: Anti HAV and anti HBs status in children with chronic liver disease at a super speciality centre: need for urgent vaccinationArun Kumar Sharma, Post Graduate Institute of Medical Education and Research, India

Panel Discussion

Day 2 | August 11, 2017Endeavour

Keynote Forum09:30-10:15

Title: Why Highly Effective Drugs Are Not Enough: An Affordable Solution to Eradicating HCVAnn D Kwong, Trek Therapeutics, USA

Opening Ceremonyconferenceseries.com 09:30-10:00

Page 3

10:15-11:00Title: A Virus-like Particle of HBV preS Elicits Robust Immune Responses Ming Luo, Georgia State University, USA

Networking & Refreshment Break 11:00-11:15 @ Breakout AreasSessions: Liver Diseases | Pancreatic Cancer | Hepatocellular CarcinomaSession Chair: Ann D Kwong, Trek Therapeutics, USA

Session Introduction

11:15-11:45Title: Advances in HepatologyMaxwell Chait, Columbia University, USA

11:45-12:15Title: Novel Combination of Natural Compounds GZ17-6.02 Inhibits Tumorigenesis in Pancreatic Cancer by Suppressing SHH SignalingAnimesh Dhar, Kansas University Medical Center, USA

12:15-12:45Title: Toll like receptors promote auto regulative tumor cell growth and growth factor expression in pancreatic cancerMartin Gasser and Ana Maria Waaga-Gasser, University of Wuerzburg, Germany

12:45-13:15Title: The Cost of Managing Severe Acute Pancreatitis in Critical CareMichae Jones, Imperial College, London

Lunch Break 13:15-14:00 @ RBGPoster Presentations 14:00-14:30 @ Meeting Halls

Poster Judge: Animesh Dhar, Kansas University Medical Center, USA

HEP01Title: AKR7A3 suppresses tumorigenicity and chemoresistance in hepatocellular carcinoma through attenuation of ERK, c-Jun and NF-κB signaling pathwaysSarah Zijun Xian, The University of Hong Kong, Hong Kong

HEP02Title: The impact of IL-6 levels to activate immune system as pro-inflammatory properties in patients with CHB infectionHyun Woong Lee, Chung-Ang University, Korea

HEP03

Title: Improvement of patients' understanding and accessibility to healthcare services increase implementation of hepatitis C virus therapy in methadone maintenance treatment patientsRafael Bruck, Tel Aviv University, Israel

HEP04Title: The Global Burden of Hepatitis C in relation to Sustainable Development Goals 2030 targetsRuchika Sharma, Decision Resources Group, India

HEP05Title: Use of differential temperature evaluation as feedback for insulin delivery monitoring in acute severe (life threatening) glucose metabolism disordersVary Coulic, Translational Medicine Laboratory, Belgium

HEP06Title: The Global Burden of Hepatitis C: A 10-year ForecastSeth Kuranz, Decision Resources Group, USA

HEP07Title: Effects of a national plan for hepatitis B and C to hospitalization due to hepatitis B and C related liver diseaseYu-Jou Tsai, Yuan’s General Hospital, Taiwan

14:30-15:00Title: Impaired homocysteine metabolism in patients with alcoholic liver disease in TaiwanSuh Ching Yang, Taipei Medical University, Taiwan

15:00-15:30Title: Discovery and quantitation of novel liver fibrosis biomarkers in hepatitis C patientsBevin Gangadharan, University of Oxford, UK

15:30-16:00Title: Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancerQingyong Ma, Xi'an Jiaotong University, China

Networking & Refreshment Break 16:00-16:15 @ Breakout Areas

16:15-16:45Title: Cost-effectiveness of maternal antiviral treatment for further preventing mother-to-infant hepatitis B virus transmission in ChinaJuan Yin, Xi’an Jiaotong University, China

Page 4

16:45-17:15Title: Down-regulation of miR-185 in liver fibrosis correlates with RHEB and RICTOR overexpression and HSCs activationJun Cheng, Peking University, China

Young Researcher Forum

17:15-17:45Title: Berberine protects acute liver failure in mice through inhibiting inflammation and apoptosisLulu Xu, China Pharmaceutical University, China

17:45-18:15 Title: Knowledge, attitude and practice of Sudanese house officers and registrars regarding pancreatic cancer in three hospitals in Khartoum state, Sudan 2016-2017Mansour Osman Elhaj, University of Khartoum, Sudan

Panel DiscussionAwards & Closing Ceremony

Day 3 | August 12, 2017Networking & Lunch 12:30-13:30 @ RBG

Bookmark your dates

E: hepatitis@gastroconferences.com; hepatitis@gastroconferences.org; hepatitis@annualconferences.orgW: hepatitis.conferenceseries.com

E: pancreas@gastroenterologysociety.com; pancreas@pulsusmeetings.org W: pancreas.cmesociety.com

April 10-12, 2018 Amsterdam, Netherlands

6th World Congress on

Hepatitis & Liver Diseases

June 11-13, 2018 Rome, Italy

3rd International Conference on

Pancreatic Cancer & Liver Diseases